Scleroderma. Progressive Systemic Sclerosis
Conditions
Interventions
Intervention 1: Ginkgo biloba, Oral Tab 40 mg, Tds , for 3 months. Intervention 2: Placebo, Oral Tab , Tds , for 3 months.
Treatment - Drugs
Placebo
Ginkgo biloba, Oral Tab 40 mg, Tds , for 3 months
Placebo, Oral Tab , Tds , for 3 months
Sponsors
Vice Chancellor for Research of Mashhad University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: suffering from scleroderma, suffering from Raynaud's phenomenon, primary level of education, age more than 18 and less than 50 years old, signing the informed consent Exclusion criteria: consumption of use anticoagulants, consumption of NSAIDs, consumption of mono amino Oxidase inhibitors
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stiffness of the skin. Timepoint: Every months till 3 month. Method of measurement: Modified Rodnan Skin Score.;Raynaud's Condition. Timepoint: before treatment and at the end of months 1 , 2 , 3. Method of measurement: Raynaud's Condition Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Interval of Raynaud's attack. Timepoint: every month till 3 month. Method of measurement: Patient examination and his/her statement about the condition of his/ her sickness. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamad Hassan Jokar
Mashhad University of Medical Sciences and Health Services
Outcome results
None listed